Within the TCGA data, breast cancer (odds ratio 2.26, 95% CI [1.04, 4.78], p = 0.025, Fisher’s exact test) and lung adenocarcinoma (odds ratio 3.71, 95% CI [1.61, 8.07], p = 0.0011, Fisher’s exact test) were more common among samples with 3ʹ VMP1 fusions; breast cancer also among tumors with 5ʹ VMP1 fusions (odds ratio 4.58, 95% CI [1.08, 22.14], p = 0.019, Fisher’s exact test; see Fig. 4c). The gene discussed is VMP1; the disease is lung adenocarcinoma.